Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Delcath Systems Inc (DCTH)

Delcath Systems Inc (DCTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,096
  • Shares Outstanding, K 17,465
  • Annual Sales, $ 3,410 K
  • Annual Income, $ -19,220 K
  • 60-Month Beta 0.63
  • Price/Sales 0.61
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 6.48
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/27/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1000 +20.00%
on 06/18/19
0.1450 -17.24%
on 06/14/19
-0.0095 (-7.34%)
since 05/24/19
3-Month
0.0667 +79.91%
on 04/15/19
0.2750 -56.36%
on 03/26/19
-0.1400 (-53.85%)
since 03/25/19
52-Week
0.0667 +79.91%
on 04/15/19
10.3000 -98.83%
on 09/19/18
-2.4800 (-95.38%)
since 06/25/18

Most Recent Stories

More News
Results of Single Center Prospective Study on Delcath's PHP Therapy Presented at ECIO 2019

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that results from a prospective phase 2 study...

DCTH : 0.1200 (+0.33%)
Delcath Joins the Ocular Melanoma Community in Recognizing Rare Disease Day

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, highlights the experiences of patients with ocular melanoma...

DCTH : 0.1200 (+0.33%)
Delcath Announces Health Authority Approval for CHEMOSAT in Brazil

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company has received medical device approval...

DCTH : 0.1200 (+0.33%)
Delcath Announces Acceptance of Abstract for Oral Presentation at ECIO 2019

Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces an abstract from a prospective phase 2 study conducted...

DCTH : 0.1200 (+0.33%)
Biotech Stocks to Watch

HENDERSON, NV / ACCESSWIRE / February 5, 2019 / In January, the trend in biotech stocks appeared to be on a positive sloping trajectory as the IBB capped off its strongest month in almost a year. Below...

CRON : 15.79 (-1.86%)
CARA : 19.73 (+0.82%)
DCTH : 0.1200 (+0.33%)
EYEN : 4.32 (unch)
Best Ways to Play Biotech Rally

HENDERSON, NV / ACCESSWIRE / January 23, 2019 / The market reached a level toward the end of last year where investors and analysts were throwing the "R" word (recession) around. The cause of this bearish...

CLDX : 2.52 (-2.33%)
GNMX : 0.17 (-9.42%)
GERN : 1.46 (-3.95%)
DCTH : 0.1200 (+0.33%)
HSGX : 0.20 (+2.67%)
Biotech Stocks on the Move

HENDERSON, NV / ACCESSWIRE / January 21, 2019 / Biotech has been one of the hottest sectors this month. Investors are intrigued by the increase in M&A. Now's a great time to start researching some oversold...

TCON : 0.76 (+8.57%)
TYME : 1.03 (+0.98%)
ZIOP : 5.63 (+3.30%)
DCTH : 0.1200 (+0.33%)
MNKD : 1.12 (+1.82%)
Biotech Companies to Watch

HENDERSON, NV / ACCESSWIRE / January 10, 2019 / Biotech has started 2019 off with a bang. Below are a few that you should be paying attention to.

AMRN : 18.17 (-1.36%)
DCTH : 0.1200 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade DCTH with:

Key Turning Points

2nd Resistance Point 0.1260
1st Resistance Point 0.1230
Last Price 0.1200
1st Support Level 0.1165
2nd Support Level 0.1130

See More

52-Week High 10.3000
Fibonacci 61.8% 6.3909
Fibonacci 50% 5.1834
Fibonacci 38.2% 3.9758
Last Price 0.1200
52-Week Low 0.0667

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar